What are the symptoms of lidocaine (local anesthetic) toxicity, including metallic taste?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lidocaine toxicity is a serious condition that can progress rapidly, and immediate action is necessary if a patient reports a metallic taste or exhibits other symptoms of toxicity, such as perioral numbness, lightheadedness, or tinnitus, during local anesthesia administration. The symptoms of lidocaine toxicity can be divided into mild and severe manifestations. Mild symptoms include:

  • Perioral numbness
  • Metallic taste
  • Lightheadedness
  • Tinnitus These symptoms can progress to more severe manifestations, such as:
  • Confusion
  • Seizures
  • Respiratory depression
  • Cardiovascular collapse According to a recent study 1, minor adverse events, including metallic taste, were reported in 6.8% of patients who received intravenous lidocaine. The study also highlighted the importance of careful dosing and monitoring to prevent catastrophic events.

The administration of intravenous lipid emulsion is recommended for local anesthetic poisoning, and benzodiazepines should be used to treat seizures associated with local anesthetic systemic toxicity 1. To prevent toxicity, it is essential to:

  • Aspirate before injecting to avoid intravascular administration
  • Inject slowly
  • Use the minimum effective dose
  • Consider using formulations with epinephrine (unless contraindicated) to slow systemic absorption In cases of life-threatening toxicity, additional treatments, such as sodium bicarbonate for wide-complex tachycardia and atropine for bradycardia, may be necessary 1.

From the FDA Drug Label

Central nervous system manifestations are excitatory and/or depressant and may be characterized by light-headedness, nervousness, apprehension, euphoria, confusion, dizziness, drowsiness, tinnitus, blurred or double vision, vomiting, sensations of heat, cold or numbness, twitching, tremors, convulsions, unconsciousness, respiratory depression and arrest. Restlessness, anxiety, tinnitus, dizziness, blurred vision, tremors, depression or drowsiness may be early warning signs of central nervous system toxicity.

The symptoms of lidocaine toxicity include:

  • Central nervous system manifestations:
    • Excitatory: light-headedness, nervousness, apprehension, euphoria, tinnitus, twitching, tremors
    • Depressant: confusion, dizziness, drowsiness, blurred or double vision, vomiting, sensations of heat, cold or numbness, convulsions, unconsciousness, respiratory depression and arrest
  • Early warning signs: restlessness, anxiety, tinnitus, dizziness, blurred vision, tremors, depression or drowsiness However, metallic taste is not mentioned as a symptom of lidocaine toxicity in the provided drug labels 2, 2, 2.

From the Research

Symptoms of Lidocaine Toxicity

The symptoms of lidocaine toxicity, also known as local anesthetic systemic toxicity (LAST), include:

  • Numbness of the tongue 3
  • Dizziness 3
  • Tinnitus 3
  • Visual disturbances 3
  • Muscle spasms 3
  • Convulsions 3, 4
  • Coma 3
  • Respiratory and cardiac arrest 5, 3, 6
  • Paresthesias of the mouth and face 4
  • Spasticity 4
  • Irritability 4
  • Diffuse tremors 4
  • Metallic taste is not explicitly mentioned in the provided studies, but it is a known symptom of local anesthetic toxicity

Treatment of Lidocaine Toxicity

Lidocaine toxicity can be effectively treated with lipid emulsion therapy 5, 3, 6, 7. The mechanism of action of lipid emulsion therapy is not well defined, but it has been postulated to work by both a "lipid sink," decreasing circulating amounts of drugs to the periphery, or through a direct "energy source" to the myocardium 6. Intravenous lipid emulsion (ILE) has become the first-line treatment for LAST and has achieved notable success in the treatment of LAST 7.

Related Questions

What is the relationship between lidocaine (local anesthetic) toxicity and metallic taste?
What are the symptoms of lidocaine (local anesthetic) toxicity?
What is the likelihood of developing lidocaine (local anesthetic) toxicity in a 72.72 kg patient who received 3cc's of 1% lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) and 30cc's of 2% lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) over 3 hours for local anesthesia?
What is the likelihood of local anesthetic systemic toxicity (LAST) in a 78kg patient given 36ccs of 2% lidocaine (lidocaine) without epinephrine (adrenaline) over 3 hours?
What is the likelihood of local anesthetic systemic toxicity (LAST) in a 77.2 Kg patient administered 36cc's of lidocaine (local anesthetic) without epinephrine (adrenergic receptor agonist) over 3 hours?
What is the differential diagnosis for a 30-year-old male with a lumbar contusion (lumbar bruise) who develops swelling of the left upper leg after a fall?
What is the relationship between lidocaine (local anesthetic) toxicity and metallic taste?
What is the literature on urethral injury from vaginal birth with a Foley catheter (Foley catheter) in place during the pushing stage?
What is Extracorporeal Shock Wave Therapy (ESWT)?
What wavelengths of light therapy are most effective for promoting scalp hair growth without the use of minoxidil (Rogaine)?
What is the efficacy of Extracorporeal Shock Wave Therapy (ESWT) for treating tendonopathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.